Scientific Program - ICPOC 2026

Note: This is a tentative scientific program and is subject to change. The final schedule will be announced closer to the event date.

Refine the list (min. 2 characters)

Keynote Presentation (In-Person)

Thomas J. Webster, Speaker at Cancer Science and Research Conference

Title: Anti-cancer nanomedicine in humans: A review and future directions

This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More

Thomas J. Webster, Brown University, United States

Keynote Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: an option for clinical oncologists, caregiv-ers and consumers to secure the human biosafety

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Oral Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer

A comprehensive molecular tumor analysis integrating a combination of NGS methods including whole-exome (WES), whole-genome (WGS) and transcriptome sequencing (RNAseq) offers the best chance for personalizing cancer care, enlarging the scope of therapy choices and offering potent [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Oral Presentation (In-Person)

Sebastiano Venturi, Speaker at Oncology Conference

Title: Iodine and Caesium-137: Angels and Demons of evolutionary Biology, in Pancreatic Cancer and Diabetes

The Chernobyl nuclear accident, on 1986, marked a turning point in both the history of energy production and our understanding of the relationship between human technology and life. J.R. Oppenheimer evoked the famous Hindu scripture, “Now I am become Death, the&nb [....] » Read More

Sebastiano Venturi, Department of Public Health of Rimini, Italy

Oral Presentation (In-Person)

Shanza Waseem, Speaker at Cancer Science and Research Conference

Title: Precision Oncology in Gynecologic Cancers: Molecular Taxonomy, Biomarker-Guided Therapeutics, and the Challenge of Therapeutic Resistance

Background: The clinical management of gynecologic malignancies—endometrial (EC), ovarian (OC), and cervical (CC) carcinomas—has been historically guided by histomorphology and staging. This paradigm fails to capture profound molecular heterogeneity, resulting in [....] » Read More

Shanza Waseem, Sichuan University, China

Oral Presentation (In-Person)

JiaLiang Chen, Speaker at Cancer Science and Research Conference

Title: Polyphyllin D Inhibits Chaperone-Mediated Autophagy by Targeting the HSC70-LAMP2A Interaction in Non-Small Cell Lung Cancer

Background and Purpose: Chaperone-mediated autophagy (CMA) is a selective degradation pathway that is highly active in various malignancies, including non-small cell lung cancer (NSCLC), and contributes to tumor progression. Currently, no targeted chemical inhibitors of CMA [....] » Read More

JiaLiang Chen, Shaanxi University of Traditional Chinese Medicine, China

Poster Presentation (In-Person)

Yin Liu, Speaker at Cancer Conferences

Title: Integrative analysis reveals immune heterogeneity and immune regulatory genes in KRAS-mutant lung adenocarcinoma

Introduction: The tumor immune microenvironment (TIME) of KRAS-mutant lung adenocarcinoma (LUAD) is predominantly characterized by an immunosuppressive phenotype, which underpins its resistance to immunotherapy. This study aims to elucidate the role and molecular mechanism o [....] » Read More

Yin Liu, Shanghai Pulmonary Hospital, China

Keynote Presentation (Virtual)

Paulo Cesar De Morais, Speaker at Oncology Conference

Title: Prospecting fluorine-doped graphene in photodynamic therapy

Halogen-decorated graphene quantum dots (X@GQDs) will be herein explored as a material platform for application in photodynamic therapy (PDT). GQDs have been extensively studied in biomedical areas such as bioimaging, bio-sensing and photothermal therapy due to their superior opt [....] » Read More

Paulo Cesar De Morais, Catholic University of Brasilia, Brazil

Keynote Presentation (Virtual)

Dmitri Lapotko, Speaker at Oncology Conference

Title: Non-Stationary External Energy Mechanisms in Cancer Diagnostics and Treatment

We explore the transformative potential of external energy in diagnosing and treating cancers at their core. The goal is to replace often harmful substances (like drugs) in patients with on-demand diagnostic and therapeutic events at the cellular level: - By combining physics, n [....] » Read More

Dmitri Lapotko, Scorpido Photonics, Inc, United States

Keynote Presentation (Virtual)

Rajvir Dahiya, Speaker at Cancer Science and Research Conference

Title: Precision oncology and blood-based mRNA genomics technology for cancer diagnosis and treatment

Current screening methods—radiological imaging, DNA-based tests, and pathological assessments—often fail to detect malignancies at early stages. Despite technological advances, gene-based diagnostics specifically designed for early cancer detection remain limited. To [....] » Read More

Rajvir Dahiya, University of California San Francisco School of Medicine, United States

Oral Presentation (Virtual)

Tanja Obradovic, Speaker at Cancer Conferences

Title: How to chose right Clinical Research Organization (CRO) partner when developing new cancer drug while meeting challenges of current critical trends in oncology drug development?

During the last decade there have been major breakthroughs in cancer treatment options driven by immunotherapy and most recently cell and gene products. With increased number of new cancer drug candidates entering clinical development there is elevated need for identification of [....] » Read More

Tanja Obradovic, Arc Nouvel LLC, United States

Oral Presentation (Virtual)

Yacob mathai Kunnathazhath, Speaker at Cancer Science and Research Conference

Title: A new Universal Fever Definition and the unscientific nature of the conservative fever definition.

No medical textbook tells us what the purpose of fever is. Without knowing this, no one in the world can define, test, or treat fever. The current definition, testing, and treatment of fever, which is constructed without knowing what the purpose of fever is, has no scientific bas [....] » Read More

Yacob mathai Kunnathazhath, Marma Health Centre, India

Oral Presentation (Virtual)

Ling Yin, Speaker at Oncology Conference

Title: Targeting Hspd1 Attenuates Neuroinflammation and Promotes Functional Recovery After Intracerebral Hemorrhage

Background: Intracerebral hemorrhage (ICH) triggers a profound neuroinflammatory cascade in which microglial polarization critically influences secondary brain injury and neurological outcomes. Clinical data revealed that Hspd1 expression is significantly elevated in circulating [....] » Read More

Ling Yin, Vice Dean, College of Life Sciences, Weifang Institute of Technology, China

Oral Presentation (Virtual)

Saba Beigh, Speaker at Cancer Science and Research Conference

Title: Molecular Disruption of Pulmonary Surfactant Proteins by Airborne Pollutants: An Integrative In-Silico Toxicology Approach

Pulmonary surfactant proteins (SP-A, SP-B, SP-C, and SP-D) are essential regulators of alveolar surface tension and pulmonary immune defense, constituting a critical frontline barrier against airborne xenobiotics. Increasing environmental pollution exposes the respiratory system [....] » Read More

Saba Beigh, Al-Baha University, Saudi Arabia

Oral Presentation (Virtual)

Alexandru Calin Grigorescu, Speaker at Oncology Conference

Title: Real world cancer pain incidence and treatment in daily hospital

Background: Approximately 34-67 percent of cancer patients experience an episode of uncontrolled pain during the course of their disease, depending on the stage. Aims: to provide real world data for pain prevalence, diagnosis and treatment recommendations on integrative model [....] » Read More

Alexandru Calin Grigorescu, Clinical Hospital for Nephrology "Dr Carl Davila", Romania

Oral Presentation (Virtual)

K R Muralidhar, Speaker at Oncology Conference

Title: Non-Coplanar Volumetric Modulated Arc Therapy for Brain Tumours Using an O-Ring Gantry Linear Accelerator: A Dosimetric Evaluation

Purpose: This study evaluates the dosimetric advantages of Non-Coplanar Volumetric Modulated Arc Therapy (ncVMAT) over Coplanar Volumetric Modulated Arc Therapy (cVMAT) enabled by a novel O-ring gantry that permits couch rotation for Brain Tumours. Methods: Fifteen p [....] » Read More

K R Muralidhar, Physics Karkinos Healthcare Private Limited, India

Oral Presentation (Virtual)

Vladan Radosavljevic, Speaker at Oncology Conference

Title: Assessing Human Exposure to Key Chemical Carcinogens Diagnostic Approaches and Interpretation

Chemical carcinogens classified by the International Agency for Research on Cancer (IARC) as Group 1 very probably contribute to cancer occurrence in over 13.5 million people and death from cancer in over seven million people. In percent, chemical elements and chemical compounds [....] » Read More

Vladan Radosavljevic, Institute of epidemiology, Military Medical Academy, Serbia

Oral Presentation (Virtual)

Vladan Radosavljevic, Speaker at Oncology Conference

Title: Radosavljevic urinary screening biomarkers of the key chemical carcinogens for bladder cancer

The aim of the study was to examine the possibility of using the urinary concentration of 1-hydroxypyrene for screening high-risk male individuals for bladder cancer. Radosavljevi?′s urinary screening protocol for the key chemical carcinogens used. Numerical data were arith [....] » Read More

Vladan Radosavljevic, Institute of epidemiology, Military Medical Academy, Serbia

Oral Presentation (Virtual)

Delacour Delphine, Speaker at Oncology Conference

Title: Decoding intestinal crypt morphogenesis: From tissue mechanics to tumor initiation

Intestinal cancers are among the most prevalent epithelial malignancies and constitute a major clinical burden, largely due to late diagnosis and difficulty of predicting disease progression. Tumorigenesis mainly initiates within intestinal crypts, which harbor stem cell (SC) and [....] » Read More

Delacour Delphine, CNRS, France

Oral Presentation (Virtual)

Constantinos M Mikelis, Speaker at Oncology Conference

Title: The small GTPase RhoA regulates the endothelial barrier during metastasis

The endothelial barrier plays an active role in transendothelial tumor cell migration during metastasis, however, the endothelial regulatory elements of this step remain obscure. Here we show that endothelial RhoA activation is a determining factor during this process. Breast tum [....] » Read More

Constantinos M Mikelis, University of Patras, Greece

Poster Presentation (Virtual)

Abir Biswas, Speaker at Oncology Conference

Title: Effect of Posaconazole Compared to Other Antifungal Drugs in Survival & Prevention of Infection in Patients with Haematological Malignancy: A Systematic Review

Background: Patients with acute leukemia who experience neutropenia after intensive chemotherapy have a high risk of developing Invasive Fungal Infections (IFIs), which can be life threatening. Although diagnostics and supportive care have been enhanced, IFIs continue to be a maj [....] » Read More

Abir Biswas, Sher-E- Bangla Medical College, Bangladesh

Poster Presentation (Virtual)

Yuxuan Li, Speaker at Cancer Science and Research Conference

Title: NK cell-associated longnon-coding RNAs reveal heterogeneity of colorectalcancer immune microenvironment

This study establishes a validated prognostic model based on NK cell-associated long noncoding RNAs (lncRNAs) to predict outcomes in colorectal cancer (CRC), a malignancy characterized by poor prognosis and limited response to conventional therapies. By integrating single-cell RN [....] » Read More

Yuxuan Li, The Second Affiliated Hospital of Kunming Medical University, China

Poster Presentation (Virtual)

Li Jinze, Speaker at Cancer Conferences

Title: NK cell–associated LncRNA signature predicts prognosis and immune landscape in hepatocellular carcinoma

The purpose of this investigation was to develop and validate a risk model based on natural killer (NK) cell-associated lncRNAs to predict outcomes in individuals with hepatocellular carcinoma (HCC). To further explore the role of NK cells in the HCC tumor microenvironment, we le [....] » Read More

Li Jinze, The Second Affiliated Hospital of Kunming Medical University, China
To be updated shortly...

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top